vs

Side-by-side financial comparison of LifeStance Health Group, Inc. (LFST) and MARCUS CORP (MCS). Click either name above to swap in a different company.

LifeStance Health Group, Inc. is the larger business by last-quarter revenue ($382.2M vs $193.5M, roughly 2.0× MARCUS CORP). On growth, LifeStance Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs 2.8%). LifeStance Health Group, Inc. produced more free cash flow last quarter ($46.6M vs $26.4M). Over the past eight quarters, MARCUS CORP's revenue compounded faster (18.2% CAGR vs 12.8%).

Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.

Marcus & Millichap, Inc. is an American company that provides real estate brokerage, mortgage brokerage, research, and advisory services in the U.S. and Canada in the field of commercial property. It popularized the practice of listing properties exclusively with one brokerage firm. The company has over 1,800 employees in more than 80 offices across the U.S. and Canada.

LFST vs MCS — Head-to-Head

Bigger by revenue
LFST
LFST
2.0× larger
LFST
$382.2M
$193.5M
MCS
Growing faster (revenue YoY)
LFST
LFST
+14.7% gap
LFST
17.4%
2.8%
MCS
More free cash flow
LFST
LFST
$20.3M more FCF
LFST
$46.6M
$26.4M
MCS
Faster 2-yr revenue CAGR
MCS
MCS
Annualised
MCS
18.2%
12.8%
LFST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LFST
LFST
MCS
MCS
Revenue
$382.2M
$193.5M
Net Profit
$11.7M
Gross Margin
Operating Margin
4.7%
0.9%
Net Margin
3.1%
Revenue YoY
17.4%
2.8%
Net Profit YoY
264.1%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LFST
LFST
MCS
MCS
Q4 25
$382.2M
$193.5M
Q3 25
$363.8M
$210.2M
Q2 25
$345.3M
$206.0M
Q1 25
$333.0M
$148.8M
Q4 24
$325.5M
$188.3M
Q3 24
$312.7M
$232.7M
Q2 24
$312.3M
$176.0M
Q1 24
$300.4M
$138.5M
Net Profit
LFST
LFST
MCS
MCS
Q4 25
$11.7M
Q3 25
$1.1M
$16.2M
Q2 25
$-3.8M
$7.3M
Q1 25
$709.0K
$-16.8M
Q4 24
$-7.1M
$986.0K
Q3 24
$-6.0M
$23.3M
Q2 24
$-23.3M
$-20.2M
Q1 24
$-21.1M
$-11.9M
Operating Margin
LFST
LFST
MCS
MCS
Q4 25
4.7%
0.9%
Q3 25
2.0%
10.8%
Q2 25
-0.9%
6.3%
Q1 25
0.5%
-13.7%
Q4 24
0.3%
-1.2%
Q3 24
0.0%
14.1%
Q2 24
-5.1%
1.3%
Q1 24
-5.6%
-12.0%
Net Margin
LFST
LFST
MCS
MCS
Q4 25
3.1%
Q3 25
0.3%
7.7%
Q2 25
-1.1%
3.6%
Q1 25
0.2%
-11.3%
Q4 24
-2.2%
0.5%
Q3 24
-1.9%
10.0%
Q2 24
-7.5%
-11.5%
Q1 24
-7.0%
-8.6%

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LFST
LFST
MCS
MCS
Cash + ST InvestmentsLiquidity on hand
$248.6M
$23.4M
Total DebtLower is stronger
$282.8M
$159.0M
Stockholders' EquityBook value
$1.5B
$457.4M
Total Assets
$2.2B
$1.0B
Debt / EquityLower = less leverage
0.19×
0.35×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LFST
LFST
MCS
MCS
Q4 25
$248.6M
$23.4M
Q3 25
$203.9M
$7.4M
Q2 25
$188.9M
$14.9M
Q1 25
$134.3M
$11.9M
Q4 24
$154.6M
$40.8M
Q3 24
$102.6M
$28.4M
Q2 24
$87.0M
$32.8M
Q1 24
$49.5M
$17.3M
Total Debt
LFST
LFST
MCS
MCS
Q4 25
$282.8M
$159.0M
Q3 25
$284.6M
$162.0M
Q2 25
$286.4M
$179.9M
Q1 25
$288.2M
$198.9M
Q4 24
$290.0M
$159.1M
Q3 24
$287.3M
$173.1M
Q2 24
$288.0M
$175.7M
Q1 24
$288.8M
$169.8M
Stockholders' Equity
LFST
LFST
MCS
MCS
Q4 25
$1.5B
$457.4M
Q3 25
$1.5B
$454.3M
Q2 25
$1.5B
$448.4M
Q1 25
$1.5B
$441.8M
Q4 24
$1.4B
$464.9M
Q3 24
$1.4B
$462.3M
Q2 24
$1.4B
$449.4M
Q1 24
$1.4B
$459.3M
Total Assets
LFST
LFST
MCS
MCS
Q4 25
$2.2B
$1.0B
Q3 25
$2.1B
$1.0B
Q2 25
$2.1B
$1.0B
Q1 25
$2.1B
$1.0B
Q4 24
$2.1B
$1.0B
Q3 24
$2.1B
$1.0B
Q2 24
$2.1B
$1.1B
Q1 24
$2.1B
$1.0B
Debt / Equity
LFST
LFST
MCS
MCS
Q4 25
0.19×
0.35×
Q3 25
0.19×
0.36×
Q2 25
0.19×
0.40×
Q1 25
0.20×
0.45×
Q4 24
0.20×
0.34×
Q3 24
0.20×
0.37×
Q2 24
0.20×
0.39×
Q1 24
0.20×
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LFST
LFST
MCS
MCS
Operating Cash FlowLast quarter
$57.6M
$48.8M
Free Cash FlowOCF − Capex
$46.6M
$26.4M
FCF MarginFCF / Revenue
12.2%
13.6%
Capex IntensityCapex / Revenue
2.9%
11.6%
Cash ConversionOCF / Net Profit
4.93×
TTM Free Cash FlowTrailing 4 quarters
$110.0M
$989.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LFST
LFST
MCS
MCS
Q4 25
$57.6M
$48.8M
Q3 25
$27.3M
$39.1M
Q2 25
$64.4M
$31.6M
Q1 25
$-3.1M
$-35.3M
Q4 24
$62.3M
$52.6M
Q3 24
$22.7M
$30.5M
Q2 24
$44.1M
$36.0M
Q1 24
$-21.8M
$-15.1M
Free Cash Flow
LFST
LFST
MCS
MCS
Q4 25
$46.6M
$26.4M
Q3 25
$17.0M
$18.2M
Q2 25
$56.6M
$14.7M
Q1 25
$-10.3M
$-58.3M
Q4 24
$56.0M
$27.1M
Q3 24
$17.7M
$12.0M
Q2 24
$39.0M
$16.1M
Q1 24
$-26.9M
$-30.5M
FCF Margin
LFST
LFST
MCS
MCS
Q4 25
12.2%
13.6%
Q3 25
4.7%
8.7%
Q2 25
16.4%
7.1%
Q1 25
-3.1%
-39.2%
Q4 24
17.2%
14.4%
Q3 24
5.7%
5.2%
Q2 24
12.5%
9.2%
Q1 24
-9.0%
-22.0%
Capex Intensity
LFST
LFST
MCS
MCS
Q4 25
2.9%
11.6%
Q3 25
2.8%
9.9%
Q2 25
2.2%
8.2%
Q1 25
2.2%
15.5%
Q4 24
1.9%
13.5%
Q3 24
1.6%
7.9%
Q2 24
1.6%
11.3%
Q1 24
1.7%
11.1%
Cash Conversion
LFST
LFST
MCS
MCS
Q4 25
4.93×
Q3 25
25.34×
2.41×
Q2 25
4.32×
Q1 25
-4.36×
Q4 24
53.31×
Q3 24
1.31×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LFST
LFST

Segment breakdown not available.

MCS
MCS

Theatres$123.1M64%
Concessions$51.0M26%
Food And Beverage$21.2M11%

Related Comparisons